Address:

Johns Hopkins School of Medicine
600 N. Wolfe Street
Carnegie 568
Baltimore, MD 21287

Appointment Phone:

443-442-2000

Fax:

443-442-2018

Medical School:
Johns Hopkins University School of Medicine

Residency:
Johns Hopkins Hospital

Current Position:
Cardiology Fellow - Year 3

Publications:
1.    Nagy CD, Campbell CY, Blumenthal RS. Dyslipidemia and atherosclerosis in women. In: The Johns Hopkins Book of Dyslipidemia. Kwiterovich P (ed), Saunders, 2009 (in preparation).

2.    Campbell CY, Clarke W, Park H, Haq N, Barone BB, Brotman DJ. Usefulness of cystatin C and prognosis following admission for acute heart failure.Am J Cardiol. 2009 Aug 1; 104(3):389-92. Epub 2009 Jun 6.

3.    Narla V, Santos RD, Campbell CY, Carvalho JA, Nasir K, Budoff MJ, Blumenthal RS, Michos ED. Coronary artery calcification and inflammation according to various metabolic syndrome definitions.J Cardiometab Syndr. 2009 Winter; 4(1):33-9.

4.    Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, Lange RA, Topol EJ, Willerson JT, Desai MY, Davidson MH, Mora S. The use of high-sensitivity assays for C-reactive protein in clinical practice.Nat Clin Pract Cardiovasc Med. 2008 Oct; 5(10):621-35. Epub 2008 Aug 19. Review.

5.    Pollin IS, Kral BG, Shattuck T, Sadler MD, Boyle JR, McKillop L, Campbell CY, Ashen MD, Nasir K, Redberg RF, Brintzenhofeszoc K, Blumenthal RS, Michos ED. High Prevalence of Cardiometabolic Risk Factors in Women Considered Low Risk by Traditional Risk Assessment. Journal of Women's Health. 2008 Jul-Aug; 17:947-53.

6.    Campbell CY, Nasir K, Carvalho JA, Blumenthal RS, Santos RD. The metabolic syndrome adds incremental value to the Framingham risk score in identifying asymptomatic individuals with higher degrees of inflammation.J Cardiometab Syndr. 2008 Winter; 3(1):7-11.

7.    Campbell CY, Rivera JJ, Blumenthal RS. Residual risk in statin-treated patients: future therapeutic options.Curr Cardiol Rep. 2007 Nov; 9(6):499-505. Review.

8.    Campbell CY, Nasir K, Sarwar A, Meneghelo RS, Carvalho JA, Blumenthal RS, Santos RD. Combined effect of high low-density lipoprotein cholesterol and metabolic syndrome on subclinical coronary atherosclerosis in white men without clinical evidence of myocardial ischemia.Am J Cardiol. 2007 Sep 1; 100(5):840-3. Epub 2007 Jun 18.

9.    Abraham J, Campbell CY, Cheema A, Gluckman TJ, Blumenthal RS, Danyi P. C-reactive protein in cardiovascular risk assessment: a review of the evidence.J Cardiometab Syndr. 2007 Spring; 2(2):119-23. Review.

10.    Campbell CY, Record JD, Kolandaivelu A, Ziegelstein RC. Chest pain in a young basketball player.J Gen Intern Med. 2006 Jun; 21(6):C7-10.

11.    Campbell CY, Nasir K, Wong ND, Blumenthal RS. Role of atherosclerosis assessment and other novel markers in the metabolic syndrome.Metab Syndr Relat Disord. 2006 Winter; 4(4):261-9.

12.    Nasir K, Campbell CY, Santos RD, Roguin A, Braunstein JB, Carvalho JA, Blumenthal RS.  The association of subclinical coronary atherosclerosis with abdominal and total obesity in asymptomatic men.Prev Cardiol. 2005 Summer; 8(3):143-8.

13.    Campbell CY, Nasir K, Blumenthal RS. Metabolic syndrome, subclinical coronary atherosclerosis, and cardiovascular risk.Am Heart Hosp J. 2005 Spring; 3(2):105-10. Review.